Virgin Galactic (SPCE) closed the most recent trading day at $12.37, moving -0.16% from the previous trading session. This change lagged the S&P 500's 0.28% gain on the day. At the same time, the Dow added 0.11%, and the tech-heavy Nasdaq gained 0.14%.Coming into today, shares of the company had lost 15.43% in the past month. In that same time, the Aerospace sector gained 3.58%, while the S&P 500 gained 0.12%.Wall Street will be looking for positivity from Virgin Galactic as it approaches its next earnings report date. In that report, analysts expect Virgin Galactic to post earnings of -$0.43 per share. This would mark a year-over-year decline of 38.71%.Investors should also note any recent changes to analyst estimates for Virgin Galactic. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Virgin Galactic is holding a Zacks Rank of #3 (Hold) right now.The Aerospace - Defense industry is part of the Aerospace sector. This group has a Zacks Industry Rank of 239, putting it in the bottom 7% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Virgin Galactic Holdings, Inc. (SPCE): Free Stock Analysis Report To read this article on Zacks.com click here.